Temporal Relationships Between Circulating Levels of CC and CXC Chemokines and Developing Atherosclerosis in Apolipoprotein E*3 Leiden Mice

Epigenetic Mechanisms in Vascular Inflammation: Modulation of Endothelial Adhesion Molecules and Endothelium-Leukocyte Adhesion

Monocytic C-C chemokine receptor 5 expression increases in in vitro intermittent hypoxia condition and in severe obstructive sleep apnea patients

Frontiers Proteoglycans in Obesity-Associated Metabolic Dysfunction and Meta-Inflammation

Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets - ScienceDirect

PDF) Whole body and hematopoietic ADAM8 deficiency does not influence advanced atherosclerotic lesion development, despite its association with human plaque progression

JCI - CXCL5 limits macrophage foam cell formation in atherosclerosis

Chemokines as Therapeutic Targets in Cardiovascular Disease

Identification of heterogeneous subsets of aortic interleukin-17A-expressing CD4+ T cells in atherosclerotic mice - Guizhen Lin, Lei Zhang, Zheng Yan, Wei Jiang, Beibei Wu, Dongsheng Li, Xiaofang Xiong, 2022

Molecular Biology of Atherosclerosis

PDF) Differential Influence of Chemokine Receptors CCR2 and CXCR3 in Development of Atherosclerosis In Vivo

Gregory BENSON, Director, BSc, PhD, Drug Development Services